Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery Plus Palliative Chemotherapy or In-Front Surgery Alone

Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery Plus Palliative Chemotherapy or In-Front Surgery Alone

The survival benefits of conversion surgery in patients with metastatic gastric cancer (mGC) remain unclear. Thus, this study aimed to determine the outcomes of conversion surgery compared to in-front surgery plus palliative chemotherapy (PCT) or in-front surgery alone for mGC. We recruited 182 cons...

Full description

Bibliographic Details
Main Authors:	Ruo-Yi Huang, Hao-Wei Kou, Puo-Hsien Le, Chia-Jung Kuo, Tsung-Hsing Chen, Shang-Yu Wang, Jen-Shi Chen, Ta-Sen Yeh, Jun-Te Hsu
Format:	Article
Language:	English
Published:	MDPI AG 2022-04-01
Series:	Journal of Personalized Medicine
Subjects:	conversion surgery metastatic gastric cancer chemotherapy outcomes
Online Access:	https://www.mdpi.com/2075-4426/12/4/555

Similar Items

Reply to Mazzei et al. Some Concerns from a Radiological Point of View. Comment on “Huang et al. Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery plus Palliative Chemotherapy or In-Front Surgery Alone. <i>J. Pers. Med.</i> 2022, <i>12</i>, 555”
by: Hao-Wei Kou, et al.
Published: (2022-06-01)

Some Concerns from a Radiological Point of View. Comment on Huang et al. Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery Plus Palliative Chemotherapy or In-Front Surgery Alone. <i>J. Pers. Med.</i> 2022, <i>12</i>, 555
by: Maria Antonietta Mazzei, et al.
Published: (2022-06-01)

Impact of Surgery and Chemotherapy on Metastatic Extrauterine Leiomyosarcoma
by: Yoshinori Imura, et al.
Published: (2022-03-01)

Role of Surgery in Metastatic Melanoma and Review of Melanoma Molecular Characteristics
by: Kulkaew Sukniam, et al.
Published: (2024-03-01)

Front-Line Bevacizumab plus Chemotherapy with or without Maintenance Therapy for Metastatic Breast Cancer: An Observational Study by the Hellenic Oncology Research Group
by: Stefania Kokkali, et al.
Published: (2022-02-01)

SUBMIT: Systemic therapy with or without up front surgery of the primary tumor in breast cancer patients with distant metastases at initial presentation
by: Ruiterkamp Jetske, et al.
Published: (2012-04-01)

SHORT-TERM RESULTS OF SIMULTANEOUS SURGERIES AT METASTATIC COLORECTAL CANCER
by: A. S. Zagaynov, et al.
Published: (2017-02-01)

Surgery for metastatic epidural spinal cord compression in thoracic spine, anterior or posterior approach?
by: Jen-Chung Liao, et al.
Published: (2022-04-01)

Current Status of the Use of Salvaged Blood in Metastatic Spine Tumour Surgery
by: Naresh Kumar, et al.
Published: (2018-09-01)

Comparison of the oncological outcomes of stenting as a bridge to surgery and surgery alone in stages II to III obstructive colorectal cancer: a retrospective study
by: Hiroaki Uehara, et al.
Published: (2022-06-01)

The Role of Primary Surgery in De Novo Metastatic Breast Carcinoma
by: Berkay Demirors, et al.
Published: (2023-04-01)

Prognostic Significance of Perineural Invasion in Patients with Stage II/III Gastric Cancer Undergoing Radical Surgery
by: Yi-Fu Chen, et al.
Published: (2022-06-01)

Primary debulking surgery for metastatic cervical adenocarcinoma: A case report
by: Sara M. Davenport, et al.
Published: (2015-11-01)

Role of Surgery in Metastatic Breast Cancer: Insights from a Narrative Review
by: Alghamdi MAA, et al.
Published: (2023-05-01)

Low neighborhood socioeconomic status is associated with higher mortality and increased surgery utilization among metastatic breast cancer patients
by: Oindrila Bhattacharyya, et al.
Published: (2021-10-01)

Role of minimally invasive surgery in the treatment of gallbladder metastatic melanoma. A review of the literature and a case report
by: Petros Ioannis Bangeas, et al.
Published: (2022-07-01)

Cancer‐directed surgery in patients with metastatic cancer: A systematic review and meta‐analysis of randomized evidence
by: Mary Kathryn Abel, et al.
Published: (2023-07-01)

Ramucirumab plus triplet chemotherapy as an alternative salvage treatment for patients with metastatic colorectal cancer
by: Yi-Hsin Liang, et al.
Published: (2022-10-01)

Primary surgery versus no surgery in synchronous metastatic breast cancer: patient-reported quality-of-life outcomes of the prospective randomized multicenter ABCSG-28 Posytive Trial
by: V. Bjelic-Radisic, et al.
Published: (2020-05-01)

A real-world evidence of efficacy of palliative gastrectomy plus chemotherapy in metastatic gastric cancer patients
by: Yang LP, et al.
Published: (2019-05-01)

Intramedullary rod failure in metastatic breast cancer: Do triple negative cancer patients have more revision surgery?
by: Ana C. Belzarena, et al.
Published: (2021-06-01)

Expected motor function change following decompressive surgery for spinal metastatic disease
by: Bernard K. Okai, BS, et al.
Published: (2023-09-01)

Performance status dynamics during treatment with nab-paclitaxel plus gemcitabine versus gemcitabine alone for metastatic pancreatic cancer
by: Chiorean EG, et al.
Published: (2018-05-01)

Hyperthermic intraperitoneal chemotherapy following up-front cytoreductive surgery versus cytoreductive surgery alone for isolated synchronous colorectal peritoneal metastases: A retrospective, observational study
by: Xiusen Qin, et al.
Published: (2022-10-01)

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for clinical node‐negative esophageal carcinoma
by: Hui‐Jiang Gao, et al.
Published: (2020-09-01)

Palliative Surgery in General Surgery Clinics
by: Adem AKÇAKAYA
Published: (2022-10-01)

Precise joint preserving surgery by using Three-Dimensional Printing Technology for metastatic periacetabular bone tumor: A technique note and preliminary report
by: Chun-Liang Hsu, et al.
Published: (2023-07-01)

Effect of the Timing of Surgery on Neurological Recovery for Patients with Incomplete Paraplegia Caused by Metastatic Spinal Cord Compression
by: Cui Y, et al.
Published: (2021-08-01)

Metastatic Tumor Dormancy in Cutaneous Melanoma: Does Surgery Induce Escape?
by: William W. Tseng, et al.
Published: (2011-02-01)

Impact of primary resistance to front-line targeted therapy in metastatic renal cell carcinoma on subsequent immune-checkpoint-inhibition
by: J. H. Börner, et al.
Published: (2023-09-01)

Cost-Effectiveness of Avelumab Maintenance Therapy Plus Best Supportive Care vs. Best Supportive Care Alone for Advanced or Metastatic Urothelial Carcinoma
by: Qian Xie, et al.
Published: (2022-04-01)

Minimally invasive “separation surgery” plus adjuvsant stereotactic radiotherapy in the management of spinal epidural metastases
by: Mazda K Turel, et al.
Published: (2017-01-01)

A prospective longitudinal study investigating outcomes including patient-reported outcome measures after surgery for metastatic bone disease: protocol for the BoMA-PRO multi-centre MBD outcomes study
by: Samantha Downie, et al.
Published: (2021-02-01)

Delay of Surgery for Spinal Metastasis due to the COVID-19 Outbreak Affected Patient Outcomes
by: Chia-Jung Hsieh, et al.
Published: (2023-12-01)

Corrigendum: Cost-effectiveness of avelumab maintenance therapy plus best supportive care vs. best supportive care alone for advanced or metastatic urothelial carcinoma
by: Qian Xie, et al.
Published: (2022-07-01)

GENERATING FACTORS OF FEELINGS TO PATIENTS INTO HOSPITAL IN FRONT OF SURGERIES CANCELLATION SITUATIONS
by: Hérica Kelly Costa, et al.
Published: (2002-06-01)

Choice of Treatment for Patients With Non–small-cell Lung Cancer >5 cm Between Surgery Alone and Surgery Plus Adjuvant Radiotherapy
by: Boyan Wang, et al.
Published: (2021-03-01)

Multi-disciplinary surgery for simultaneous resection of multiple tumors in a patient with newly diagnosed metastatic pheochromocytoma/paraganglioma
by: Jibo Jing, et al.
Published: (2023-10-01)

Anti‐epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first‐line treatment for recurrent or metastatic nasopharyngeal carcinoma
by: Chen Chen, et al.
Published: (2020-03-01)

Cetuximab Plus Chemotherapy versus Chemotherapy Alone in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Cost-Effectiveness Analysis
by: Lang Y, et al.
Published: (2020-11-01)